While these drugs are effective, recent studies show a decline in long-term efficacy, which is believed to result from the emergence of VEGF-independent mechanisms involved in exacerbating the abnormal angiogenic milieu in the AMD eye. The gene discussed is VEGFA; the disease is age-related macular degeneration.